We have collected information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn't a assurance of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. Franklin Resources, Inc.
67.92% Payout Ratio
Franklin Resources, Inc. is a publicly owned asset management holding company.
According to Morningstar, Inc., the next dividend pay date is on Sep 28, 2020, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 4.51%.
Franklin Resources, Inc. sales growth this year is expected to be 32.4% and a negative 0.3% for next year.
Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 5.57B for the twelve trailing months.
Franklin Resources, Inc.'s sales growth for the next quarter is 42.3%. The company's growth estimates for the ongoing quarter and the next is 4.5% and 6.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.88%.
Franklin Resources, Inc.'s Stock Top and Bottom Yearly Value
Franklin Resources, Inc.'s stock is valued at $23.98 at 21:58 EST, way below its 52-week high of $27.60 and way above its 52-week low of $14.91.
Franklin Resources, Inc.'s Moving Average
Franklin Resources, Inc.'s value is way higher than its 50-day moving average of $21.34 and way higher than its 200-day moving average of $21.26.
2. Kellogg Company
66.09% Payout Ratio
Kellogg Company, together with its subsidiaries, manufactures and markets ready-to-eat cereal and convenience foods.
As stated by Morningstar, Inc., the next dividend pay date is on Nov 29, 2020, the estimated forward annual dividend rate is 2.28 and the estimated forward annual dividend yield is 3.68%.
Kellogg Company sales growth this year is anticipated to be 1.5% and a negative 2% for next year.
Year-on-year quarterly revenue growth grew by 1.7%, now sitting on 13.53B for the twelve trailing months.
Kellogg Company's sales growth for the next quarter is a negative 2.5%. The company's growth estimates for the ongoing quarter and the next is a negative 3.3% and negative -1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.15%.
Kellogg Company's Stock Top and Bottom Yearly Value
Kellogg Company's stock is valued at $61.98 at 21:58 EST, way below its 52-week high of $72.88 and way higher than its 52-week low of $52.66.
Kellogg Company's Moving Average
Kellogg Company's worth is below its 50-day moving average of $64.07 and below its 200-day moving average of $66.15.
3. Taitron Components Incorporated
175% Payout Ratio
Taitron Components Incorporated engages in the supply of original designed and manufactured (ODM) electronic components, and distribution of brand name electronic components.
As stated by Morningstar, Inc., the next dividend pay date is on Nov 11, 2020, the estimated forward annual dividend rate is 0.14 and the estimated forward annual dividend yield is 5.16%.
Taitron Components Incorporated sales growth this year is anticipated to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 6.74M for the twelve trailing months.
Taitron Components Incorporated's sales growth is a negative 0% for the ongoing quarter and negative 0% for the next. The company's growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.86%.
Taitron Components Incorporated's Stock Top and Bottom Yearly Value
Taitron Components Incorporated's stock is valued at $2.80 at 21:58 EST, way under its 52-week high of $3.99 and way above its 52-week low of $2.02.
Taitron Components Incorporated's Moving Average
Taitron Components Incorporated's value is higher than its 50-day moving average of $2.63 and way above its 200-day moving average of $2.51.
4. Nuveen California Municipal Value Fund, Inc.
113.1% Payout Ratio
Nuveen California Municipal Value Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc.
According to Morningstar, Inc., the next dividend pay date is on Dec 13, 2020, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 3.03%.
Nuveen California Municipal Value Fund, Inc. sales growth this year is expected to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 4.5%, now sitting on 10.89M for the twelve trailing months.
Nuveen California Municipal Value Fund, Inc.'s sales growth is a negative 0% for the current quarter and negative 0% for the next. The company's growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.63%.
Nuveen California Municipal Value Fund, Inc.'s Stock Top and Bottom Yearly Value
Nuveen California Municipal Value Fund, Inc.'s stock is valued at $10.50 at 21:58 EST, under its 52-week high of $10.98 and way higher than its 52-week low of $8.74.
Nuveen California Municipal Value Fund, Inc.'s Moving Average
Nuveen California Municipal Value Fund, Inc.'s value is above its 50-day moving average of $10.32 and higher than its 200-day moving average of $10.43.
5. NetApp, Inc.
63.16% Payout Ratio
NetApp, Inc. provides software, systems, and services to manage and share data on-premises, and private and public clouds worldwide.
As stated by Morningstar, Inc., the next dividend pay date is on Jan 6, 2021, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 3.28%.
NetApp, Inc. sales growth this year is anticipated to be 3.7% and 3.9% for next year.
Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 5.52B for the twelve trailing months.
NetApp, Inc.'s sales growth for the next quarter is 4.6%. The company's growth estimates for the present quarter and the next is a negative 13.8% and negative -7.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 151.66%.
NetApp, Inc.'s Stock Top and Bottom Yearly Value
NetApp, Inc.'s stock is valued at $59.99 at 21:58 EST, below its 52-week high of $65.38 and way higher than its 52-week low of $34.66.
NetApp, Inc.'s Moving Average
NetApp, Inc.'s worth is way higher than its 50-day moving average of $49.65 and way higher than its 200-day moving average of $45.40.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
